Why is $BIOA stock moving today?
BioAge Labs, Inc. Common Stock
Why is $BIOA moving today?
The likely driver
BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk
GlobeNewswire Inc.·8:00 AM ETpositive
Price
$22.95
Move today
+0.0%
Volume vs avg
0.0x
Scanner alerts today
0
Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.